Is Medroxyprogesterone Acetate Tablet (Provera) in shortage?
Medroxyprogesterone Acetate Tablet is listed by FDA as being discontinued by at least one maker (updated Aug 31, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- PROVERA, Tablet, 10 mg (NDC 0009-0051-01)
Discontinuation of the manufacture of the drug; Withdrawal from sale expected September 2026.
Maker contact: 800-533-4535
- PROVERA, Tablet, 2.5 mg (NDC 0009-0065-01)
Discontinuation of the manufacture of the drug; Withdrawal from sale expected early October 2026.
Maker contact: 800-533-4535
FDA recalls of Medroxyprogesterone Acetate
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Medroxyprogesterone Acetate Tablet:
- Eugia US LLC recalls medroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL, Rx only, 1 mL Single-Dose Vial, Mfd in India for:
- SUN PHARMACEUTICAL INDUSTRIES INC recalls medroxyPROGESTERone Acetate Injectable Suspension, USP, 1 mL Prefilled Syringe, 150 mg/mL, Rx only, Manufactured by Sun
Medroxyprogesterone Acetate Tablet shortage questions
Is Medroxyprogesterone Acetate Tablet (Provera) in shortage?
Medroxyprogesterone Acetate Tablet is listed by FDA as being discontinued by at least one maker (updated Aug 31, 2026).
What should I do if I can’t get Medroxyprogesterone Acetate Tablet?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.